Serological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu

Parasites and Vectors

Volumn 10, Issue 1, 2017, Pages

  Idris, Zulkarnain Md ^a,b   Chan, Chim W ^a   Mohammed, Mubasher ^a   Kalkoa, Morris ^c   Taleo, George ^c   Junker, Klara ^d,e   Arcà, Bruno ^f   Drakeley, Chris ^d   Kaneko, Akira ^a,g,h  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c Ministry of Health   (Vanuatu)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e CARLSBERG LABORATORY   (Denmark)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NAGASAKI UNIVERSITY   (Japan)

Author keywords

Anopheles; Island; ITN; Malaria; Plasmodium falciparum; Plasmodium vivax; Serology

Indexed keywords

GSG6 ANTIGEN; PARASITE ANTIGEN; RECOMBINANT APICAL MEMBRANE ANTIGEN 1; RECOMBINANT MEROZOITE SURFACE ANTIGEN 1; UNCLASSIFIED DRUG; INSECT PROTEIN; PROTOZOON ANTIBODY; SALIVA PROTEIN;

ADOLESCENT; ADULT; ANOPHELES GAMBIAE; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CHILD; CODOMINANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HEALTH PROGRAM; HUMAN; INFANT; INSECTICIDE TREATED NET; MALARIA; MALARIA CONTROL PROGRAM; MALE; MICROSCOPY; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SCHOOL CHILD; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; SPLEEN SIZE; VANUATU; ANIMAL; ANOPHELES; BLOOD; GROWTH, DEVELOPMENT AND AGING; HEALTH SERVICES RESEARCH; IMMUNOLOGY; MOSQUITO CONTROL; PROCEDURES; SEROEPIDEMIOLOGY; UTILIZATION;

ANIMALS; ANOPHELES; ANTIBODIES, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEALTH SERVICES RESEARCH; HUMANS; INSECT PROTEINS; INSECTICIDE-TREATED BEDNETS; MALARIA; MOSQUITO CONTROL; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SALIVARY PROTEINS AND PEPTIDES; SEROEPIDEMIOLOGIC STUDIES; VANUATU;

EID: 85018621829     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-017-2139-z     Document Type: Article

References (49)

1. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci USA. 2005;102:5108-13.
2. Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, Amran J, et al. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis. 2010;16:392-9.
3. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One. 2009;4:e6083.
4. van den Hoogen LL, Griffin JT, Cook J, Sepulveda N, Corran P, Conway DJ, et al. Serology describes a profile of declining malaria transmission in Farafenni. Gambia Malar J. 2015;14:416.
5. Bruce-Chwatt LJ, Draper CC, Avramidis D, Kazandzoglou O. Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg. 1975;78:194-200.
6. Bruce-Chwatt LJ, Draper CC, Konfortion P. Seroepidemiological evidence of eradication of malaria from Mauritius. Lancet. 1973;2:547-51.
7. Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J. 2010;9:169.
8. Zakeri S, van den Hoogen LL, Mehrizi AA, Karimi F, Raeisi A, Drakeley C. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran. Malar J. 2016;15:382.
9. Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, et al. Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea. PLoS One. 2011;6:e25137.
10. Kaneko A, Taleo G, Kalkoa M, Yaviong J, Reeve PA, Ganczakowski M, et al. Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago. Acta Trop. 1998;70:285-302.
11. World Health Organization. World Malaria Report. Geneva: WHO; 2015.
12. Chaves LF, Kaneko A, Taleo G, Pascual M, Wilson ML. Malaria transmission pattern resilience to climatic variability is mediated by insecticide-treated nets. Malar J. 2008;7:100.
13. Sinka ME, Bangs MJ, Manguin S, Chareonviriyaphap T, Patil AP, Temperley WH, et al. The dominant Anopheles vectors of human malaria in the Asia-Pacific region: occurrence data, distribution maps and bionomic precis. Parasit Vectors. 2011;4:89.
14. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, Bjorkman A. Malaria eradication on islands. Lancet. 2000;356:1560-4.
15. Atkinson JA, Fitzgerald L, Toaliu H, Taleo G, Tynan A, Whittaker M, et al. Community participation for malaria elimination in Tafea Province, Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease. Malar J. 2010;9:93.
16. The Pacific Malaria Initiative Survey Group (PMISG) on behalf of the Ministries of Health of Vanuatu and Solomon Islands. Malaria on isolated Melanesian islands prior to the initiation of malaria elimination activities. Malar J. 2010;9:218.
17. Kaneko A, Chaves LF, Taleo G, Kalkoa M, Isozumi R, Wickremasinghe R, et al. Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu. Infect Immun. 2014;82:243-52.
18. Poinsignon A, Cornelie S, Ba F, Boulanger D, Sow C, Rossignol M, et al. Human IgG response to a salivary peptide, gSG6-P1, as a new immuno-epidemiological tool for evaluating low-level exposure to Anopheles bites. Malar J. 2009;8:198.
19. Rizzo C, Lombardo F, Ronca R, Mangano V, Sirima SB, Nebie I, et al. Differential antibody response to the Anopheles gambiae gSG6 and cE5 salivary proteins in individuals naturally exposed to bites of malaria vectors. Parasit Vectors. 2014;7:549.
20. Rizzo C, Ronca R, Fiorentino G, Mangano VD, Sirima SB, Nebie I, et al. Wide cross-reactivity between Anopheles gambiae and Anopheles funestus SG6 salivary proteins supports exploitation of gSG6 as a marker of human exposure to major malaria vectors in tropical Africa. Malar J. 2011;10:206.
21. Doucoure S, Drame PM. Salivary biomarkers in the control of mosquito-borne diseases. Insects. 2015;6:961-76.
22. Watanabe N, Kaneko A, Yamar S, Leodoro H, Taleo G, Tanihata T, et al. Determinants of the use of insecticide-treated bed nets on islands of pre- and post-malaria elimination: an application of the health belief model in Vanuatu. Malar J. 2014;13:441.
23. Mills AR. A malaria survey of Futuna in the New Hebrides. J Trop Med Hyg. 1954;57:99-107.
24. Chaves LF, Taleo G, Kalkoa M, Kaneko A. Spleen rates in children: an old and new surveillance tool for malaria elimination initiatives in island settings. Trans R Soc Trop Med Hyg. 2011;105:226-31.
25. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J, et al. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J. 2008;7:195.
26. Troye-Blomberg M, Perlmann H, Patarroyo ME, Perlmann P. Regulation of the immune response in Plasmodium falciparum malaria. II. Antigen specific proliferative responses in vitro. Clin Exp Immunol. 1983;53:345-53.
27. Ihalamulla RL, Mendis KN. Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation. Trans R Soc Trop Med Hyg. 1987;81:25-8.
28. Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol. 2007;23:575-82.
29. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64:97-106.
30. Childs DZ, Cattadori IM, Suwonkerd W, Prajakwong S, Boots M. Spatiotemporal patterns of malaria incidence in northern Thailand. Trans R Soc Trop Med Hyg. 2006;100:623-31.
31. Wong J, Hamel MJ, Drakeley CJ, Kariuki S, Shi YP, Lal AA, et al. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009. Malar J. 2014;13:451.
32. Supargiyono S, Bretscher MT, Wijayanti MA, Sutanto I, Nugraheni D, Rozqie R, et al. Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia. Malar J. 2013;12:444.
33. Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Claes F, et al. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia. Malar J. 2012;11:86.
34. Sepulveda N, Drakeley C. Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar J. 2015;14:141.
35. Sepulveda N, Paulino CD, Drakeley C. Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate. Malar J. 2015;14:529.
36. Proietti C, Verra F, Bretscher MT, Stone W, Kanoi BN, Balikagala B, et al. Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda. Parasite Immunol. 2013;35:164-73.
37. Stone W, Bousema T, Jones S, Gesase S, Hashim R, Gosling R, et al. IgG responses to Anopheles gambiae salivary antigen gSG6 detect variation in exposure to malaria vectors and disease risk. PLoS One. 2012;7:e40170.
38. Rizzo C, Ronca R, Fiorentino G, Verra F, Mangano V, Poinsignon A, et al. Humoral response to the Anopheles gambiae salivary protein gSG6: a serological indicator of exposure to Afrotropical malaria vectors. PLoS One. 2011;6:e17980.
39. Lanfrancotti A, Lombardo F, Santolamazza F, Veneri M, Castrignano T, Coluzzi M, Arca B. Novel cDNAs encoding salivary proteins from the malaria vector Anopheles gambiae. FEBS Lett. 2002;17:67-71.
40. Calvo E, Dao A, Pham VM, Ribeiro JM. An insight into the sialome of Anopheles funestus reveals an emerging pattern in anopheline salivary protein families. Insect Biochem Mol Biol. 2007;37:164-75.
41. Arca B, Struchiner CJ, Pham VM, Sferra G, Lombardo F, Pombi M, Ribeiro JM. Positive selection drives accelerated evolution of mosquito salivary genes associated with blood-feeding. Insect Mol Biol. 2014;23:122-31.
42. Neafsey DE, Waterhouse RM, Abai MR, Aganezov SS, Alekseyev MA, Allen JE, et al. Mosquito genomics. Highly evolvable malaria vectors: the genomes of 16 Anopheles mosquitoes. Science. 2015;347:1258522.
43. Remoue F, Cisse B, Ba F, Sokhna C, Herve JP, Boulanger D, Simondon F. Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans R Soc Trop Med Hyg. 2006;100:363-70.
44. Drame PM, Poinsignon A, Besnard P, Le Mire J, Dos-Santos MA, Sow CS, et al. Human antibody response to Anopheles gambiae saliva: an immuno-epidemiological biomarker to evaluate the efficacy of insecticide-treated nets in malaria vector control. Am J Trop Med Hyg. 2010;83:115-21.
45. Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto JC, et al. Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS One. 2010;5:e15596.
46. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.
47. Steenkeste N, Rogers WO, Okell L, Jeanne I, Incardona S, Duval L, et al. Sub-microscopic malaria cases and mixed malaria infection in a remote area of high malaria endemicity in Rattanakiri province, Cambodia: implication for malaria elimination. Malar J. 2010;9:108.
48. Waltmann A, Darcy AW, Harris I, Koepfli C, Lodo J, Vahi V, et al. High rates of asymptomatic, sub-microscopic Plasmodium vivax infection and disappearing Plasmodium falciparum malaria in an area of low transmission in Solomon Islands. PLoS Negl Trop Dis. 2015;9:e0003758.
49. Idris ZM, Chan CW, Kongere J, Gitaka J, Logedi J, Omar A, et al. High and heterogeneous prevalence of asymptomatic and sub-microscopic malaria infections on islands in Lake Victoria, Kenya. Sci Rep. 2016;6:36958.